Are You Getting the Most Specific and Consistent Data from Your Protein Microarrays?

Find out how Sengenics can take your autoantibody biomarker program to the next level

Sengenics patented KREX protein folding technology ensures all array proteins are correctly folded, full-length and functional resulting in exceptional binding specificity and inter- & intra-array reproducibility.

Biomarker Discovery

Identification of autoantibody biomarker signatures

Response Prediction

Predict responders, non-responders and those at risk for adverse events

Patient Stratification

Intra-disease stratification, identification of cohorts and clinical trial patient enrichment

CDx Development

Establish biomarker signatures for companion diagnostic development

Cancer Prediction

Unique differential profiling of cancer-antigens in various cancer types

biologically meaningful hits and
actionable data

Discover how our highly specific protein arrays translates to more accurate results

View our KREX technology in action

Sengenics Off-the-Shelf and Custom Protein Microarrays

Sengenics - Functional Proteomics | Krex Technology | Protein Microarray Supplier

Sengenics, a functional proteomics company, leverages its patented KREX protein folding technology to discover autoantibody biomarker signatures for drug response prediction, patient stratification and development of CDx. Our technology ensures that all microarray proteins are full-length, correctly folded and functional, enabling specific and quantitative antibody binding to conformational epitopes.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389